Literature DB >> 6225801

Spleen cell-mediated suppression of IgG production to a non-parasite antigen during chronic Trypanosoma cruzi infection in mice.

S G Reed, S B Roters, E A Goidl.   

Abstract

Splenic plaque-forming cell (PFC) responses to TNP-BGG (thymus-dependent) and TNP-Ficoll (thymus-independent) were measured during acute and chronic T. cruzi infections produced in C57BL/10 mice. The number of anti-TNP PFC to both antigens was suppressed as has been shown. Approximately 40% of untreated mice survived acute disease to enter chronic T. cruzi infection characterized by a decrease in parasitemia, a reduction in spleen size, a return to normal of the IgM responses to TNP-BGG and TNP-Ficoll, persistant polyclonal activation, and continued suppression of the IgG responses to TNP-BGG. Mice that were drug-treated during the acute disease had high survival rates and similar immune response patterns, ie., suppressed IgG PFC responses to TNP-BGG and normal IgM PFC responses to TNP-BGG and TNP-Ficoll. The selective suppression of the IgG response was transferred to nonirradiated syngeneic recipients by Thy-1.2-positive cells present in the spleens of chronically infected mice. These observations may be interpreted to suggest the persistence of nonspecific suppressor T cells during chronic T. cruzi infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6225801

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Repeated antigenic stimulation overcomes immunosuppression in experimental Chagas' disease.

Authors:  L Choromanski; R E Kuhn
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

2.  Impaired germinal center responses and suppression of local IgG production during intracellular bacterial infection.

Authors:  Rachael Racine; Derek D Jones; Madhumouli Chatterjee; Maura McLaughlin; Katherine C Macnamara; Gary M Winslow
Journal:  J Immunol       Date:  2010-03-29       Impact factor: 5.422

3.  Antigen-specific T-helper cells abrogate suppression in Trypanosoma cruzi-infected mice.

Authors:  D M Ritter; R E Kuhn
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

4.  Retention of anergy and inhibition of antibody responses during acute γ herpesvirus 68 infection.

Authors:  Andrew Getahun; Mia J Smith; Igor Kogut; Linda F van Dyk; John C Cambier
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

5.  Trypanosoma cruzi induces regulatory dendritic cells in vitro.

Authors:  Carolina Verónica Poncini; Catalina Dirney Alba Soto; Estela Batalla; Maria Elisa Solana; Stella Maris González Cappa
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

6.  Pneumococcal Surface Protein A Plays a Major Role in Streptococcus pneumoniae-Induced Immunosuppression.

Authors:  Lindsey Pujanauski; Jesus Colino; Michael Flora; Raul M Torres; Elaine Tuomanen; Clifford M Snapper
Journal:  J Immunol       Date:  2016-03-30       Impact factor: 5.422

7.  Immunosuppressive property within the Streptococcus pneumoniae cell wall that inhibits generation of T follicular helper, germinal center, and plasma cell response to a coimmunized heterologous protein.

Authors:  Swadhinya Arjunaraja; Lindsey Pujanauski; Jesus Colino; Raul M Torres; Clifford M Snapper
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

8.  Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease.

Authors:  L Choromanski; R E Kuhn
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  Use of parasite antigens and interleukin-2 to enhance suppressed immune responses during Trypanosoma cruzi infection in mice.

Authors:  L Choromanski; R E Kuhn
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

10.  Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.

Authors:  J S Silva; P J Morrissey; K H Grabstein; K M Mohler; D Anderson; S G Reed
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.